Elimu Informatics Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Elimu Informatics's estimated annual revenue is currently $6.9M per year.(i)
  • Elimu Informatics's estimated revenue per employee is $216,000

Employee Data

  • Elimu Informatics has 32 Employees.(i)
  • Elimu Informatics grew their employee count by 3% last year.

Elimu Informatics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.3M156-3%N/AN/A
#2
$148.5M440N/AN/AN/A
#3
$124.2M36846%N/AN/A
#4
$545.1M144217%N/AN/A
#5
$29.2M1086%N/AN/A
#6
$12.9M53N/AN/AN/A
#7
$1125.1M29146%$20.4MN/A
#8
$15.3M6315%N/AN/A
#9
$8.9M415%N/AN/A
#10
$4.3M23-15%N/AN/A
Add Company

What Is Elimu Informatics?

WE ARE DOCTORS. WE ARE NURSES. WE ARE PHARMACISTS, AND CLINICAL INFORMATICISTS. ABOVE ALL, WE ARE TECHNOLOGISTS. Elimu, pronounced “eh-lee-moo,” was founded through the merger of PSMI Consulting, and Meliorix. Our collective experience in clinical decision support, semantic normalization, and workflow integration, as well as our track record of delivering for some of the largest and most recognized names in the healthcare industry, allows us to bring together an array of exciting clinical decision support products and services to address today’s healthcare landscape. Clinical decision support fuels so many of today's initiatives. So much attention is paid to the decision support rules themselves. However, the importance of a strong data foundation to ensure the rules fire when they should, and a seamless workflow so your users can actually interact with the rules when it makes sense, are equally important. That's Elimu's philosophy and mission in healthcare - Clinical Decision Support when you need it, where you need it.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$6.9M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.4M323%N/A
#2
$3.5M320%N/A
#3
$5.4M320%N/A
#4
$3.7M3260%N/A
#5
N/A323%N/A